Top of this page
Skip navigation, go straight to the content

Clinical Study Information - UCB7665

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Study summary Publication (if available)
Myasthenia Gravis A Multicenter, Randomized, Investigator- and Subject-Blind, Placebo-Controlled, Treatment Sequence Study Evaluating the Safety, Tolerability, and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis Phase 2  MG0002
Ongoing
NCT03052751
2016-002698-36
Thrombocytopenia Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia Phase 2 TP0001
Ongoing
NCT02718716
2015-003984-12